The AMAX Destiny Plus represents the ultimate fusion of technology and economy for coagulation automation. Whether testing is geared towards routine or specialized testing or both, the AMAX Destiny Plus has the testing flexibility to provide true clot detection, and confidence in the accuracy of results.
Features Include:
Utilizes patented Ball Method Mechanical Testing technology, the Destiny Plus is the only coagulation system that can offer Mechanical and Optical clot detection on the same platform.
Mechanical testing provides reliable and accurate results on compromised samples – icteric, hemolytic, and lipemic samples
Comprehensive test menu including mechanical, optical clot-based, chromogenic and immunoturbidimetric assays
Micro testing volumes (1/4 volume) in mechanical mode
Anytime STAT testing, results provided in under 3 minutes
Continuous sample, reagent and consumable loading
Bar-coded capability for samples, sample racks and reagent racks
Reagent management by volume and number of remaining tests
Reagent expiration monitoring by label and on board time
Uninterrupted reagent refill
IntuiTouch user-friendly software with integrated reflexive testing
Throughput of up to 180 PT tests/hour and up to 90 PTT tests/hour
KC4ˆ™
For compact, powerful, reliable testing in lower-volume facilities, the flexible KC4ˆ™ hemostasis analyzer simplifies both routine and STAT testing. These systems are also ideal for use as backup analyzers.
Features:
Patented Mechanical Clot detection
Full range of clotting assays
Half-volume PT and APTT testing
Flexible instrumentation to simplify both routine and STAT testing
Four test positions with preparation area for 12 samples
37° incubation area for eight samples and five reagents
Complete data management capabilities
Programmable single and duplicate test modes
Precision monitoring of duplicate tests
Short lag time (4.6 sec) for veterinary applications
Mechanical Clot Detection –
The only true clot detection in the market
Clot detection is most critical when clotting time is abnormal. The results are so crucial that laboratories often repeat the assay because of a lack in confidence in their testing system. Trinity Biotech Hemostasis analyzers minimize the need for repeat testing through the use of patented Ball Method Technology, offering true clot detection.
Mechanical measurement methods depend on the physical formation of fibrin strands that attach to a moving mechanical device that ultimately either completes or opens an electrical circuit.
The Ball method is:
Able to detect actual clot information instead of changes in optical absorbance
Able to measure fragile clots
Result integrity unaffected by compromised samples (icteric, hemolytic and lipemic)
Insensitive to biphasic algorithm anomalies, reporting the correct result the first time, every time
